M. Martín

Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases

L. Lojo, J. Yuste, P. Richi, 2021, Vaccines.

Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study

L. Lojo, P. Richi, Ó. Illera, 2020, Clinical Rheumatology.

Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study.

L. Lojo, P. Richi, D. Sanz-Rosa, 2019, Medicina clinica.

Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study

L. Lojo, P. Richi, D. Sanz-Rosa, 2019, Medicina Clínica (English Edition).

Secukinumab does not impair the immunogenic response to the influenza vaccine in patients

I. Casas, F. de Ory, F. Cava, 2019, RMD Open.

Viruses and Mycoplasma pneumoniae are the main etiological agents of community‐acquired pneumonia in hospitalized pediatric patients in Spain

P. Rojo, J. Jensen, M. L. Herreros, 2021, Pediatric pulmonology.

Viruses and Mycoplasma pneumoniae are the main etiological agents of community‐acquired pneumonia in hospitalized pediatric patients in Spain

P. Rojo, J. Jensen, M. L. Herreros, 2021, Pediatric pulmonology.